• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国 2007 年癌症发病与死亡。

Cancer incidence and mortality in china, 2007.

机构信息

National Office for Cancer Prevention and Control/National Central Cancer Registry, Cancer Institute, Chinese Academy of Medical Sciences, Beijing 100021, China.

出版信息

Chin J Cancer Res. 2012 Mar;24(1):1-8. doi: 10.1007/s11670-012-0001-6.

DOI:10.1007/s11670-012-0001-6
PMID:23359628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3555260/
Abstract

OBJECTIVE

Cancer incidence and mortality data collected from population-based cancer registries were analyzed to present the overall cancer statistics in Chinese registration areas by age, sex and geographic area in 2007.

METHODS

In 2010, 48 cancer registries reported cancer incidence and mortality data of 2007 to National Central Cancer Registry of China. Of them, 38 registries' data met the national criteria. Incidence and mortality were calculated by cancer sites, age, gender, and area. Age-standardized rates were described by China and World population.

RESULTS

The crude incidence rate for all cancers was 276.16/100,000 (305.22/100,000 for male and 246.46/100,000 for female; 284.71/100,000 in urban and 251.07/100,000 in rural). Age-standardized incidence rates by China and World population were 145.39/100,000 and 189.46/100,000 respectively. The crude mortality rate for all cancers was 177.09/100,000 (219.15/100,000 for male and 134.10/100,000 for female; 173.55/100,000 in urban and 187.49/100,000 in rural). Age-standardized mortality rates by China and World population were 86.06/100,000 and 116.46/100,000, respectively. The top 10 most frequently common cancer sites were the lung, stomach, colon and rectum, liver, breast, esophagus, pancreas, bladder, brain and lymphoma, accounting for 76.12% of the total cancer cases. The top 10 causes of cancer death were cancers of the lung, liver, stomach, esophagus, colon and rectum, pancreas, breast, leukemia, brain and lymphoma, accounting for 84.37% of the total cancer deaths.

CONCLUSION

Cancer remains a major disease threatening people's health in China. Prevention and control should be enhanced, especially for the main cancers.

摘要

目的

分析来自基于人群的癌症登记处的癌症发病率和死亡率数据,以呈现 2007 年中国登记地区按年龄、性别和地理区域划分的总体癌症统计数据。

方法

2010 年,48 个癌症登记处向中国国家癌症中心报告了 2007 年的癌症发病率和死亡率数据。其中,38 个登记处的数据符合国家标准。按癌症部位、年龄、性别和地区计算发病率和死亡率。用中国和世界人口标化率描述年龄标准化率。

结果

所有癌症的粗发病率为 276.16/100,000(男性为 305.22/100,000,女性为 246.46/100,000;城市为 284.71/100,000,农村为 251.07/100,000)。用中国和世界人口标化的发病率分别为 145.39/100,000 和 189.46/100,000。所有癌症的粗死亡率为 177.09/100,000(男性为 219.15/100,000,女性为 134.10/100,000;城市为 173.55/100,000,农村为 187.49/100,000)。用中国和世界人口标化的死亡率分别为 86.06/100,000 和 116.46/100,000。最常见的 10 种癌症部位是肺癌、胃癌、结肠癌和直肠癌、肝癌、乳腺癌、食管癌、胰腺癌、膀胱癌、脑癌和淋巴瘤,占总癌症病例的 76.12%。癌症死亡的 10 大主要原因是肺癌、肝癌、胃癌、食管癌、结肠癌和直肠癌、胰腺癌、乳腺癌、白血病、脑癌和淋巴瘤,占总癌症死亡人数的 84.37%。

结论

癌症仍然是威胁中国人民健康的主要疾病。应加强预防和控制,特别是针对主要癌症。

相似文献

1
Cancer incidence and mortality in china, 2007.中国 2007 年癌症发病与死亡。
Chin J Cancer Res. 2012 Mar;24(1):1-8. doi: 10.1007/s11670-012-0001-6.
2
Report of incidence and mortality in China cancer registries, 2009.中国癌症登记地区 2009 年肿瘤登记发病与死亡报告
Chin J Cancer Res. 2013 Feb;25(1):10-21. doi: 10.3978/j.issn.1000-9604.2012.12.04.
3
National cancer incidence and mortality in China, 2012.2012年中国国家癌症发病率与死亡率
Chin J Cancer Res. 2016 Feb;28(1):1-11. doi: 10.3978/j.issn.1000-9604.2016.02.08.
4
Report of incidence and mortality in china cancer registries, 2008.中国癌症登记地区 2008 年肿瘤登记发病与死亡报告。
Chin J Cancer Res. 2012 Sep;24(3):171-80. doi: 10.1007/s11670-012-0171-2.
5
Annual report on status of cancer in China, 2011.《2011年中国癌症现状年度报告》
Chin J Cancer Res. 2015 Feb;27(1):2-12. doi: 10.3978/j.issn.1000-9604.2015.01.06.
6
Annual report on status of cancer in China, 2010.《中国癌症报告 2010》年度报告
Chin J Cancer Res. 2014 Feb;26(1):48-58. doi: 10.3978/j.issn.1000-9604.2014.01.08.
7
Cancer incidence and mortality in Zhejiang Province, Southeast China, 2016: a population-based study.2016 年中国东南浙江省的癌症发病与死亡情况:一项基于人群的研究。
Chin Med J (Engl). 2021 Jul 29;134(16):1959-1966. doi: 10.1097/CM9.0000000000001666.
8
Cancer incidence and mortality in Henan province, 2012.2012年河南省癌症发病率与死亡率
Chin J Cancer Res. 2016 Jun;28(3):275-85. doi: 10.21147/j.issn.1000-9604.2016.03.02.
9
The incidence and mortality of major cancers in China, 2012.2012年中国主要癌症的发病率和死亡率。
Chin J Cancer. 2016 Aug 2;35(1):73. doi: 10.1186/s40880-016-0137-8.
10
Cancer incidence and mortality in Shandong province, 2012.2012年山东省癌症发病率与死亡率
Chin J Cancer Res. 2016 Jun;28(3):263-74. doi: 10.21147/j.issn.1000-9604.2016.03.01.

引用本文的文献

1
CCL16 inhibits tumor proliferation and metastasis in HCC by impacting CK19 phenotype.CCL16 通过影响CK19表型抑制肝癌的肿瘤增殖和转移。
ILIVER. 2024 May 20;3(2):100096. doi: 10.1016/j.iliver.2024.100096. eCollection 2024 Jun.
2
Global trends and burden of brain and central nervous system cancers in adolescents and young adults GBD 2021 study.青少年和青年脑癌及中枢神经系统癌症的全球趋势与负担:全球疾病负担研究2021
Sci Rep. 2025 May 16;15(1):17049. doi: 10.1038/s41598-025-01368-6.
3
Estimating the Proportion of Overdiagnosis among Prostate, Breast, and Thyroid Cancers in China: Findings from the Global Burden of Disease 2019.估算中国前列腺癌、乳腺癌和甲状腺癌过度诊断的比例:来自 2019 年全球疾病负担研究的发现。
Curr Oncol. 2024 Sep 20;31(9):5643-5651. doi: 10.3390/curroncol31090418.
4
Prostate Cancer among Patients Undergoing Radical Cystoprostatectomy for Bladder Cancer in the Department of Urology in a Tertiary Care Centre.在一家三级医疗中心的泌尿科接受根治性膀胱切除术治疗膀胱癌的患者中的前列腺癌。
JNMA J Nepal Med Assoc. 2023 Oct 1;61(266):782-786. doi: 10.31729/jnma.8309.
5
The Increasing Burden of Cancer Among Women and in Rural Areas: A Retrospective Population-Based Study.女性和农村地区癌症负担日益加重:一项回顾性基于人群的研究。
Inquiry. 2023 Jan-Dec;60:469580231195311. doi: 10.1177/00469580231195311.
6
circPOLR1C Promotes the Development of Esophageal Cancer by Adsorbing miR-361-3p and Regulating Cancer Cell Apoptosis and Metastasis.环状POLR1C通过吸附miR-361-3p并调控癌细胞凋亡和转移促进食管癌发展。
J Oncol. 2022 Dec 23;2022:9124142. doi: 10.1155/2022/9124142. eCollection 2022.
7
Pancreatic cancer incidence and mortality patterns in 2006-2015 and prediction of the epidemiological trend to 2025 in China.2006 - 2015年中国胰腺癌的发病率和死亡率模式以及至2025年的流行病学趋势预测
World J Clin Cases. 2022 May 16;10(14):4404-4413. doi: 10.12998/wjcc.v10.i14.4404.
8
The Role of N-Methyladenosine (mA) Methylation Modifications in Hematological Malignancies.N-甲基腺苷(m⁶A)甲基化修饰在血液系统恶性肿瘤中的作用
Cancers (Basel). 2022 Jan 11;14(2):332. doi: 10.3390/cancers14020332.
9
Erectile dysfunction in nonmuscle-invasive bladder cancer patients before and after transurethral resection (TUR) of bladder tumor in China.中国 TUR 治疗膀胱肿瘤前后非肌层浸润性膀胱癌患者的勃起功能障碍。
Asian J Androl. 2022 Sep-Oct;24(5):509-512. doi: 10.4103/aja202166.
10
Diagnosis of Prostate Cancer in Patients with Prostate-Specific Antigen (PSA) in the Gray Area: Construction of 2 Predictive Models.前列腺特异性抗原(PSA)灰区患者前列腺癌的诊断:2 种预测模型的构建。
Med Sci Monit. 2021 Feb 8;27:e929913. doi: 10.12659/MSM.929913.

本文引用的文献

1
Bayesian age-period-cohort prediction of lung cancer incidence in China.贝叶斯年龄-时期-队列预测中国肺癌发病率。
Thorac Cancer. 2011 Nov;2(4):149-155. doi: 10.1111/j.1759-7714.2011.00062.x.
2
Cancer incidence and mortality in china, 2006.中国 2006 年癌症发病与死亡。
Chin J Cancer Res. 2011 Mar;23(1):3-9. doi: 10.1007/s11670-011-0003-9.
3
[Strengthening cancer registration system in China].[加强中国癌症登记系统]
Zhonghua Yu Fang Yi Xue Za Zhi. 2010 May;44(5):374-5.
4
Declining cancer mortality in the United States.美国癌症死亡率的下降。
Cancer. 1996 Nov 15;78(10):2045-8. doi: 10.1002/(sici)1097-0142(19961115)78:10<2045::aid-cncr3>3.0.co;2-n.
5
Smoking-attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States?1991年吸烟所致癌症死亡率:肺癌现在是美国吸烟者中的首要死因吗?
J Natl Cancer Inst. 1991 Aug 21;83(16):1142-8. doi: 10.1093/jnci/83.16.1142.